MINERVA NEUROSCIENCES INC (NERV) Stock News

NASDAQ:NERV - US6033802058 - Common Stock

2.435 USD

+0.02 (+0.83%)

Last: 8/22/2025, 8:27:03 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

NERV Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Benzinga - Mentions: TRIB UNH ONMD PAHC ...

12 Health Care Stocks Moving In Thursday's After-Market Session

10 days ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results

10 days ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results

3 months ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates

3 months ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates

a year ago - By: BusinessInsider

News Image

NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024

a year ago - By: InvestorPlace

NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024

4 months ago - By: Benzinga - Mentions: CRIS GOVX HCTI BSGM ...

12 Health Care Stocks Moving In Monday's After-Market Session

6 months ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates

6 months ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates

10 months ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates

10 months ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates

a year ago - By: InvestorPlace

NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024

a year ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates

a year ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates

a year ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates

a year ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates

1 years ago - By: Seeking Alpha

Minerva stock falls as FDA rejects schizophrenia drug

1 years ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

2 years ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates

2 years ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates

2 years ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates

2 years ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates

2 years ago - By: Minerva Neurosciences, Inc

Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates